About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AMRS - Amyris| Previous Close | $13.82 | Open | $14.08 |
| Volume | 4.17M | Market Cap | 3.306B |
| Yield | Last Dividend |
| Amyris Announces Participation In Upcomi... | 02/25/21 |
| EMERYVILLE, Calif., Feb. 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health an... | |
| Amyris Announces Launch of Pipette?? Cle... | 02/24/21 |
| EMERYVILLE, Calif., Feb. 24, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health an... | |
| Amyris Announces Positive Pre-Clinical R... | 02/22/21 |
| EMERYVILLE, Calif., Feb. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health an... | |
| Clean Energy Market: 2021 Industry Size,... | 02/19/21 |
| The latest report published by SMI, titled Global Clean Energy Market Report provides key information about the current status and prospects of the ma... | |
| Amyris To Host Fourth Quarter And Full Y... | 02/17/21 |
| EMERYVILLE, Calif., Feb. 17, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health an... | |
| Amyris Hosts Successful Second Session O... | 02/10/21 |
| Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and ... | |
| Cannabis Stock Gainers And Losers From F... | 02/03/21 |
| GAINERS: Medical Marijuana Inc (PINK: MJNA ) shares closed up 36.30% at $0.04 Reliq Health Technologies Inc (PINK: RQHTF ) shares closed up 33.62% at ... | |
| Amyris to Host Second Webinar in its Vir... | 02/03/21 |
| EMERYVILLE, Calif., Feb. 3, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and... | |
| Amyris Announces Breakthrough Clinical R... | 02/02/21 |
| EMERYVILLE, Calif., Feb. 2, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and... | |
| AMYRIS INVESTIGATION INITIATED by Former... | 01/22/21 |
| NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (?... | |
| Amyris Acquiring Terasana Brand To Offer... | 01/22/21 |
| EMERYVILLE, Calif., Jan. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health an... | |
| Amyris Ranked Among World's Top Social A... | 01/15/21 |
| EMERYVILLE, Calif., Jan. 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health an... | |
| Synthetic Biology Market : COVID-19 Impa... | 12/18/20 |
| Synthetic Biology Market Is Expected To Reach US$ 56,044.9 Million By 2025 From US$ 6,802.0 In 2016; It Is Estimated To Grow At A CAGR Of 28.2% From 2... | |
| Amyris Hosts Successful First Session Of... | 12/16/20 |
| EMERYVILLE, Calif., Dec. 16, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health an... | |
| Purecane, the Revolutionary Sweetener De... | 12/08/20 |
| EMERYVILLE, Calif., Dec. 8, 2020 /PRNewswire/ -- PurecaneTM a pioneering clean sweetener from Amyris, Inc. (NASDAQ: AMRS), a global science and techno... | |
| Amyris, Inc. Reports Third Quarter 2020 ... | 11/05/20 |
| EMERYVILLE, Calif., Nov. 5, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Sustainable Health and Clea... | |
| Amyris And Rosie Huntington-Whiteley Ann... | 10/30/20 |
| EMERYVILLE, Calif., Oct. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| Glancy Prongay & Murray LLP, a Leading S... | 10/23/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $AMRS #CLASSACTION--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyr... | |
| Amyris and Arzeda Enter into Development... | 10/20/20 |
| SEATTLE, Oct. 20, 2020 /PRNewswire/ -- Arzeda, the Protein Design Company???, today announced that the company has entered into a joint development ag... | |
| The Law Offices of Frank R. Cruz Announc... | 10/08/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $AMRS #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors... | |
| Amyris Delivering Sustainable Alternativ... | 10/01/20 |
| EMERYVILLE, Calif., Oct. 1, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty mar... | |
| Amyris' Pipette Clean Baby Brand Selecte... | 09/21/20 |
| EMERYVILLE, Calif., Sept. 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| Amyris Continues Market Adoption Of Its ... | 09/15/20 |
| EMERYVILLE, Calif., Sept. 15, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| Amyris to Provide Business Overview And ... | 09/14/20 |
| EMERYVILLE, Calif., Sept. 14, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| Amyris Denies 'Patent Infringement' Alle... | 09/11/20 |
| Biotech firm Amyris Inc. (NASDAQ: AMRS ) is clapping back at allegations made by Lavvan Inc. that it committed patent infringment. "Amyris is disappoi... | |
| Amyris Responds To LAVVAN's Filing Of La... | 09/11/20 |
| EMERYVILLE, Calif., Sept. 11, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| LAVVAN, Inc. Files $881 Million Federal ... | 09/10/20 |
| NEW YORK, Sept. 10, 2020 /PRNewswire/ -- LAVVAN, Inc. ("LAVVAN") today announced that it has filed an $881 million lawsuit against biotechnology compa... | |
| Amyris to Present at H.C. Wainwright 22n... | 09/08/20 |
| EMERYVILLE, Calif., Sept. 8, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| Amyris Scales First Fermentation-Based C... | 09/01/20 |
| EMERYVILLE, Calif., Sept. 1, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| INVESTOR ALERT: Monteverde & Associates ... | 07/29/20 |
| NEW YORK , July 29, 2020 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm hea... | |
| Buy rating | 02/26/21 |
| Roth Capital initiates coverage with Buy rating and announces Price Target of $20.00 | |
| Strong Buy rating | 01/06/21 |
| Cowen & Co. upgrades from Market Perform to Outperform rating and announces Price Target of $9.00 | |
| Date | 2021-03-02 (BMO) | Est. (EPS/Rev.) | ($0.09)/ 69.44M |
| Actual (EPS/Rev.) | / | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| WaveCrest - Pascal(tm) Earnings Picks | WaveCrest | 50.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
